Enzymotec Ltd
ENZY
ENZY was delisted on the 10th of January, 2018.
32 hedge funds and large institutions have $45.8M invested in Enzymotec Ltd in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 4 closing their positions.
6% less funds holding
Funds holding: 34 → 32 (-2)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
20% less capital invested
Capital invested by funds: $57.2M → $45.8M (-$11.4M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$4.99M |
| 2 |
Millennium Management
New York
|
-$1.07M |
| 3 |
GA
Gagnon Advisors
New York
|
-$394K |
| 4 |
LCM
Laurion Capital Management
New York
|
-$282K |
| 5 |
IA
Icon Advisers
Greenwood Village,
Colorado
|
-$220K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CLOS
26
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| $26K | – | – | – |
|
27
State of Tennessee, Department of Treasury
Nashville,
Tennessee
| $21K | +$21.1K | +3,198 | New |
|
|
PCM
28
Penserra Capital Management
Orinda,
California
| $20K | -$2.13K | -324 | -9% |
|
29
UBS Group
Zurich,
Switzerland
| $11K | -$4.77K | -724 | -29% |
|
30
Walleye Trading
New York
| $3K | -$3.29K | -500 | -56% |
|
31
Bank of America
Charlotte,
North Carolina
| $3K | – | – | – |
|
32
Creative Planning
Overland Park,
Kansas
| $1K | +$1.32K | +200 | New |
|
|
33
Millennium Management
New York
| – | -$1.07M | -152,938 | Closed |
|
|
IA
34
Icon Advisers
Greenwood Village,
Colorado
| – | -$220K | -31,417 | Closed |
|
|
TC
35
TFS Capital
West Chester,
Pennsylvania
| – | -$94K | -13,375 | Closed |
|
36
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -250 | Closed |
|
ENZY Hedge Fund Activity: Q4 2016 in Review
32 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q4 2016, worth a combined $45.8M — down 20% from $57.2M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ENZY and 2 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 9 added.
The largest buyer was Gagnon Securities, adding an estimated $913K. The largest seller was Goldman Sachs, cutting an estimated $4.99M.
- 32 institutional investors held Enzymotec Ltd (ENZY) as of Q4 2016, down from 34 in Q3 2016.
- Funds reported $45.8M of Enzymotec Ltd stock for Q4 2016, down 20% quarter-over-quarter.
- 2 funds opened new Enzymotec Ltd positions in Q4 2016 and 4 closed out, a net change of -2 holders.
- The largest Enzymotec Ltd buyer in Q4 2016 was Gagnon Securities, an estimated $913K added.
- The largest Enzymotec Ltd seller in Q4 2016 was Goldman Sachs, an estimated $4.99M sold.
Based on aggregated 13F filings for Q4 2016.